Expression and Immunogenicity of a Mutant Diphtheria Toxin Molecule, CRM(197), and Its Fragments in Salmonella typhi Vaccine Strain CVD 908-htrA

Documenti analoghi

• Optimization of Plasmid Maintenance in the Attenuated Live Vector Vaccine Strain Salmonella typhi CVD 908-htrA
  di: Galen, James E., et al.
  Pubblicazione: (1999)
• Adaptation of the Endogenous Salmonella enterica Serovar Typhi clyA-Encoded Hemolysin for Antigen Export Enhances the Immunogenicity of Anthrax Protective Antigen Domain 4 Expressed by the Attenuated Live-Vector Vaccine Strain CVD 908-htrA
  di: Galen, James E., et al.
  Pubblicazione: (2004)
• Helicobacter pylori Infection Affects Immune Responses Following Vaccination of Typhoid-Naive US Adults With Attenuated Salmonella Typhi Oral Vaccine CVD 908-htrA
  di: Muhsen, Khitam, et al.
  Pubblicazione: (2014)
• Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers
  di: Tacket, Carol O., et al.
  Pubblicazione: (2000)
• Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
  di: Barry, E M, et al.
  Pubblicazione: (1996)